Salesforce.com (CRM) Stock Up After Rejecting Microsoft's $55 Billion Takeover Bid

NEW YORK (TheStreet) -- Shares of Salesforce.com Inc  (CRM) are up 2.3% to $74.59 on heavy volume in afternoon trading Friday, following reports that Microsoft Corp (MSFT) offered the company $55 billion to acquire it, according to CNBC's David Faber.

The two companies were in "significant" takeover talks earlier this month that ended over price. Salesforce chairman and CEO Marc Benioff wanted as much as $70 billion, according to CNBC.

The cloud computing provider is no longer in takeover talks with Microsoft, CNBC added.

Yesterday, Salesforce shares rallied after the cloud software company surpassed analysts' earnings estimates for the first quarter and raised its full year guidance.

TheStreet's Jim Cramer, Portfolio Manager of the Action Alerts PLUS Charitable Trust Portfolio said, "Will he [Benioff] sell the company? He said don't bother him on these issues until he gets to $10 billion in revs and he passes SAP  (SAP). I take him at his word."

"No love lost between SAP and CRM. You have to listen to that Salesforce conference call to hear how tough Benioff really is. Dare I say that CRM may actually be undervalued on 2017 earnings," said Cramer Thursday morning.

About 6.94 million shares of Salesforce have changed hands as of 1:54 p.m. ET today, compared to its average trading volume of about 6.06 million shares a day.

San Francisco-based Salesforce.com is a provider of enterprise cloud computing solutions that helps with customer relationship management.

The company delivers its service through Internet browsers and mobile devices, and markets its social enterprise applications and platforms to businesses on a subscription basis, primarily through its direct sales efforts and indirectly through partners.

Insight from TheStreet's Research Team:

Jim Cramer commented on Salesforce.com in a recent post on RealMoney.com. Here is what Cramer had to say about the stock:

What can you say about a stock that sails above a potential acquisition price because the company underneath it delivers a quarterly report that exceeds anything anyone could possibly expect?

That's what happened last night with salesforce.com (CRM - Get Report), and it is a wonder to behold.

Here's a company that had more distractions than anyone could ever dream of in one three-month period: endless takeover rumors, a battle with a state governor over civil rights, a strategic review of women's pay and titles to be sure of gender equality and competitors just taking pot shots left and right.

And what does it do in those three months? How about vastly, and I mean, vastly, exceed estimates on everything from revenue growth, to gross margins, to billings, to operating cash flow?

-Jim Cramer, 'Salesforce.com May Be Cheap Still' originally published 5/21/2015 on RealMoney.com.

Want more information like this from Jim Cramer BEFORE your stock moves? Learn more about RealMoney.com now.

Separately, TheStreet Ratings team rates SALESFORCE.COM INC as a Hold with a ratings score of C. TheStreet Ratings Team has this to say about their recommendation:

"We rate SALESFORCE.COM INC (CRM) a HOLD. The primary factors that have impacted our rating are mixed, some indicating strength, some showing weaknesses, with little evidence to justify the expectation of either a positive or negative performance for this stock relative to most other stocks. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance and compelling growth in net income. However, as a counter to these strengths, we find that the company has favored debt over equity in the management of its balance sheet."

You can view the full analysis from the report here: CRM Ratings Report

More from Markets

Video: There Are Some Big Changes Coming to the PGA Championships in 2019

Video: There Are Some Big Changes Coming to the PGA Championships in 2019

Video: One-on-One With Pluralsight's CEO Following Its Successful IPO

Video: One-on-One With Pluralsight's CEO Following Its Successful IPO

CBS-Viacom Battle Comes to a Head; FDA Approves Novartis Migraine Drug --ICMYI

CBS-Viacom Battle Comes to a Head; FDA Approves Novartis Migraine Drug --ICMYI

Listen: Here's What You Need To Know About ETFs Today (Hint: They're on Fire!)

Listen: Here's What You Need To Know About ETFs Today (Hint: They're on Fire!)

Cramer and His Team Stick to Their Disciplines -- Even When It's Disappointing

Cramer and His Team Stick to Their Disciplines -- Even When It's Disappointing